Differentiation-inducing liposoluble vitamin deficiency may explain frequent secondary solid tumors after hematopoietic stem cell transplantation: Minireview

Neoplasma

Volumn 55, Issue 1, 2008, Pages 1-9

  Gedikoglu, G ^b   Altinoz, M A ^a  

^a HALIC UNIVERSITY   (Turkey)

^b NONE

Author keywords

Bone marrow transplantation; E mail: maltinoz@gmail.com; Secondary cancer; Vitamin A

Indexed keywords

ALPHA TOCOPHEROL; CYCLOPHOSPHAMIDE; ISOTRETINOIN; LINOLEIC ACID; PLACEBO; RETINOID; RETINOL; VITAMIN D; VITAMIN D DERIVATIVE;

BASAL CELL CARCINOMA; BRAIN TUMOR; CARCINOGENESIS; CHEMOPROPHYLAXIS; CHRONIC GRAFT VERSUS HOST DISEASE; DISEASE SEVERITY; DRUG EFFECT; ESOPHAGUS CANCER; HEAD AND NECK CANCER; HEAD AND NECK CARCINOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION; INFLAMMATION; INTESTINE ABSORPTION; LARYNX TUMOR; LUNG CANCER; MELANOMA; METASTASIS; MOUTH TUMOR; MUCOSA INFLAMMATION; NEOPLASM; NONHUMAN; PATIENT MONITORING; PRIMARY TUMOR; RETINOL DEFICIENCY; SHORT SURVEY; SKIN CANCER; SKIN CARCINOMA; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN DEFICIENCY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; ANIMAL; BLOOD; CELL DIFFERENTIATION; PHYSIOLOGY; REVIEW; SECOND CANCER;

ANIMALS; AVITAMINOSIS; CELL DIFFERENTIATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTESTINAL ABSORPTION; NEOPLASMS, SECOND PRIMARY; RETINOIDS; VITAMIN A; VITAMIN A DEFICIENCY; VITAMIN D DEFICIENCY;

EID: 48049120234     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (109)

1. ADES L, GUARDIOLA P, SOCIE G. Second malignancies after allogeneic hematopoietic stem cell transplantation: new insight and current problems. Blood Reviews 2002; 16: 135-146
2. BHATIA S, RAMSAY NK, STEINBUCH M, et al. Malignant neoplasms following bone marrow transplantation. Blood 1996; 87: 3633-3639 (Pubitemid 26129591)
3. DEEG HJ, SANDERS J, MARTIN P, et al. Secondary malignancies after marrow transplantation. Exp Hematol 1984; 12: 660-666
4. KOLB HJ, GUENTHER W, DUELL T, et al. Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late Effects. Bone Marrow Transplant 1992; 10 Suppl 1: 135-138
5. SOCIE G, HENRY-AMAR M, BACIGALUPO A, et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med 1993; 329:1152-1157
6. PIERGA JY, SOCIE G, GLUCKMAN E, et al. Secondary solid malignant tumors occurring after bone marrow transplantation for severe aplastic anemia given thoraco-abdominal irradiation. Radiother Oncol 1994; 30: 55-58
7. DUELL T, VAN LINT MT, LJUNGMAN P, et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med 1997; 126: 184-192
8. FETSCHER S, FINKE J, ENGELHARDT R, et al. Earlyonset secondary malignancies after high-dose chemotherapy and autologous hematopoietic stem cell transplantation.Ann Hematol 1997; 74:73-77
9. ODDOU S, VEY N, VIENS P, et al. Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution. Leuk Lymphoma 1998; 31: 187-194
10. LOWSKY R, LIPTON J, FYLES G, et al. Secondary malignancies after bone marrow transplantation in adults. J Clin Oncol 1994; 12: 2187-2192 (Pubitemid 24356038)
11. WITHERSPOON RP, FISHER L, SCHOCH G, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989; 321: 784-789 (Pubitemid 19237425)
12. SOCIE G, HENRY-AMAR M, COSSET JM, et al. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 1991; 78: 277-279
13. DEEG HJ, SOCIE G, SCHOCH G, et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia. A joint Seattle and Paris analysis of results in 700 patients. Blood 1996; 87: 386-392
14. CURTIS RE, ROWLINGS PA, DEEG HJ, et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997; 336: 897-904 (Pubitemid 27137189)
15. KOLB HJ, SOCIE G, DUELL T, et al. Malignant neoplasms in long-term survivors of bone marrow transplantation. Ann Intern Med 1999; 131: 738-744 (Pubitemid 29531982)
16. SOCIE G, CURTIS RE, DEEG HJ, et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000; 18: 348-357 (Pubitemid 30056424)
17. De BENEDETTI V, BENNETT WP, GREENBLATT MS, et al. p53 tumor suppressor gene: implications for iatrogenic cancer and cancer therapy. Med Pediatr Oncol Suppl 1996; 1: 2-11 (Pubitemid 26152695)
18. TUCKER MA, D'ANGIO GJ, BOICE JD Jr, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 1987; 317: 588-593 (Pubitemid 17126781)
19. ENG C, LI FP, ABRAMSON DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 1993; 85: 1121-1128 (Pubitemid 23212278)
20. HAWKINS MM, WILSON LM, BURTON HS, et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 1986; 88: 270-278
21. LAND CE, SAKU T, HAYASHI Y, et al. Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987: evaluation of radiation-related risk. Radiat Res 1996; 146: 28-36
22. BHATIA S, LOUIE AD, BHATIA R, et al. Solid cancers after bone marrow transplantation. J Clin Oncol 2001; 19: 464-471 (Pubitemid 32112860)
23. FAVRE-SCHMUZIGER G, HOFER S, PASSWEG J, et al. Treatment of solid tumors following allogeneic bone marrow transplantation. Bone Marrow Transplant 2000; 25: 895-898 (Pubitemid 30209684)
24. FORREST DL, NEVILL TJ, NAIMAN SC, et al. Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis. Bone Marrow Transplant 2003; 32: 915-923
25. BAKER KS, DEFOR TE, BURNS LJ, et al. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol 2003; 21: 1352-1358.
26. AU WY, CHAN EC, PANG A, et al. Nonhematologic malignancies after allogeneic hematopoietic stem cell transplantation: incidence and molecular monitoring. Bone Marrow Transplant 2004; 34: 981-985. (Pubitemid 39600116)
27. HASEGAWA W, POND GR, RIFKIND JT, et al. Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation. Bone Marrow Transplant 2005; 35: 51-55. (Pubitemid 40090056)
28. CURTIS RE, METAYER C, RIZZO JD, et al. Impact of chronic GVHD therapy on the development of squamouscell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood 2005; 105: 3802-3811.
29. SHIMADA K, YOKOZAWA T, ATSUTA Y, et al. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis. Bone Marrow Transplant 2005; 36: 115-121.
30. BROWN JR, YECKES H, FRIEDBERG JW, et al. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 2005; 23: 2208-2214.
31. WESTARP ME, WESTARP MP, GRUNDL W, et al. Improving medical approaches to primary CNS malignancies-retinoid therapy and more. Med Hypotheses 1993; 41: 267-276. (Pubitemid 23290554)
32. GUDAS LJ. Retinoids and vertebrate development. J Biol Chem. 1994; 269: 15399-15402.
33. MARK M, GHYSELINCK NB, CHAMBON P. Retinoic acid signalling in the development of branchial arches. Curr Opin Genet Dev 2004; 14: 591-598. (Pubitemid 39360308)
34. SLACK JM, TANNAHILL D. Mechanism of anteroposterior axis specification in vertebrates. Lessons from the amphibians. Development 1992; 114: 285-302.
35. GREEN JB. Retinoic acid: the morphogen of the main body axis? Bioessays 1990; 12: 437-439.
36. BOEHM N, SAMAMA B, CRIBIER B, et al. Retinoic-acid receptor beta expression in melanocytes. Eur J Dermatol 2004; 14: 19-23.
37. WATABE H, SOMA Y, ITO M, et al. All-trans retinoic acid induces differentiation and apoptosis of murine melanocyte precursors with induction of the microphthalmia-associated transcription factor. J Invest Dermatol 2002; 118: 35-42.
38. LOTAN R, LOTAN D. Stimulation of melanogenesis in a human melanoma cell line by retinoids. Cancer Res 1980; 40: 3345-3350. (Pubitemid 10043551)
39. HIGH KP, LEGAULT C, SINCLAIR JA, et al. Low plasma concentrations of retinol and alpha-tocopherol in hematopoietic stem cell transplant recipients: the effect of mucositis and the risk of infection.Am J Clin Nutr 2002; 76:1358-1366.
40. KREUTZ M, EISSNER G, HAHN J, et al. Variations in 1alpha25- dihydroxy vitamin D3 and 25-hydroxyvitamin D3 serum levels during allogeneic bone marrow transplantation. Bone Marrow Trans 2004; 33: 871-873.
41. AREKAT MR, AND G, LEMKE S, et al. Dramatic improvement of BMD following vitamin D therapy in a bone marrow transplant recipient. J Clin Densitom 2002; 5: 267-271.
42. KANANEN K, VOLIN L, TAHTELA R, et al. Recovery of bone mass and normalization of bone turnover in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Trans 2002; 29: 33-39 (Pubitemid 34126496)
43. HOLLANDER D. Intestinal absorption of vitamins A, E, D and K. J Lab Clin Med 1981; 97: 449-462
44. BLOMHOFF R, HELGERUD P, DUELAND S, et al. Lymphatic absorption and transport of retinol and Vitamin D3 from rat intestine. Evidence for different pathways. Biochim Biophys Acta 1984; 772: 109-116.
45. CHEN P, SOARES AM, LIMA AA, et al. Association of Vitamin A and zinc status with altered intestinal permeability: analyses of cohort data from northeastern Brazil. J Health Popul Nutr; 2003: 21: 309-315
46. MUIGAI R, GATEI DG, SHAUNAK S, et al. Jejunal function and pathology in visceral Leishmaniasis. Lancet 1983; 2: 476-479.
47. BERGSJO P. Gastrointestinal tract reaction to radiation therapy in cancer of the cervix measured by the vitamin A absorption test. Acta Obstet Gynecol Scand 1973; 52: 59-61.
48. LIVESEY SJ, HOLMES JA, WHITTAKER JA. Ocular complications of bone marrow transplantation. Eye 1989; 3: 271-276. (Pubitemid 20018876)
49. SOONG HK, MARTIN NF, WAGONER MD, et al. Topical retinoid therapy for squamous metaplasia of various ocular surface disorders. A multicenter, placebo-controlled double-masked study. Ophthalmology 1988; 95:1442-1446
50. MURPHY PT, SIVAKUMARAN M, FAHY G, et al. Successful use of topical retinoic acid in severe dry eye due to chronic graft-versus-host disease. Bone Marrow Transplant 1996; 18: 641-642
51. YOSHIDA A, KAWANO Y, KATO K, et al. Apoptosis in perforated cornea of a patient with graft-versus-host disease. Can J Ophthalmol 2006; 41: 472-475
52. SUZUKI M, USUI T, KINOSHITA N, et al. A case of sterile corneal perforation after bone marrow transplantation. Eye 2006 Sep 15; [Epub ahead of print]
53. YUTA K, KAMI M, MATSUMOTO Y, et al. Deep lamellar keratoplasty for corneal perforation due to chronic graft-versus- host disease following allogeneic hematopoietic stem-cell transplantation. Haematologica 2005; 90: ECR15.
54. HEINZ C, STEUHL KP, MELLER D. Corneal perforation associated with vitamin-A-deficiency. Ophthalmologe 2004; 101: 614-617
55. SANLI H, EKMEKCI P, KUSAK F, et al. Hyperkeratosis of the nipple associated with chronic graft versus host disease after allogeneic haematopoietic cell transplantation. Acta Derm Venereol 2003; 83: 385-386 (Pubitemid 37281554)
56. ALEXIS AF, BUSAM K, MYSKOWSKI PL. Porokeratosis of Mibelli following bone marrow transplantation.Int J Dermatol 2006; 45: 361-365
57. FIELDS LL, WHITE CR Jr, MAZIARZ RT. Rapid development of disseminated superficial porokeratosis after transplant induction therapy. Bone Marrow Transplant 1995; 15: 993-995
58. McCALLISTER RE, ESTES SA, YARBROUGH CL. Porokeratosis plantaris, palmaris, et disseminata. Report of a case and treatment with isotretinoin. J Am Acad Dermatol 1985; 13: 598-603
59. BUNDINO S, ZINA AM. Disseminated porokeratosis Mibelli treated with RO 10-9359. A study of two cases with ultrastructural remarks. Dermatologica 1980; 160: 328-336
60. BEERS B, KALISH RS, KAYE VN, et al. Unilateral linear lichenoid eruption after bone marrow transplantation: an unmasking of tolerance to an abnormal keratinocyte clone? J Am Acad Dermatol 1993; 28: 888-892.
61. GUNTHER S. Effectiveness of vitamin A acid in diseases of the mouth mucosa: lichen ruber planus, leukoplakias and geographic tongue. Z Hautkr 1975; 50: 41-46
62. DILEK I, DEMIRER T, USTUN C, et al. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia. Bone Marrow Transplant 1998; 21: 1159-1161 (Pubitemid 28256660)
63. SPELMAN LJ, STRUTTON GM, ROBERTSON IM, et al. Acquired ichthyosis in bone marrow transplant recipients. J Am Acad Dermatol 1996; 35: 17-20 (Pubitemid 26231316)
64. GHISLAIN PD, ROUSSEL S, MAROT L, et al. Acquired ichthyosis disclosing Hodgkin's disease. Simultaneous recurrence. Presse Med 2002; 31: 1126-1128
65. IFRAH N, BERGER F, SAINT-ANDRE JP, et al. Transient acanthosis nigricans following bone marrow transplantation for lymphoid malignancy. Bone Marrow Transplant 1990; 5: 281-282
66. AKOVBYAN VA, TALANIN NY, ARIFOV SS, et al. Successful treatment of acanthosis nigricans with etretinate. J Am Acad Dermatol 1994; 31: 118-120
67. MONTES LF, HIRSCHOWITZ BI, KRUMDIECK C. Acanthosis nigricans and hypovitaminosis A. response to topical vitamin A acid. J Cutan Pathol 1974; 1: 88-94
68. KREBS A. Acanthosis nigricans with involvement of the esophagus and vitamin A deficiency. Schweiz Med Wochenschr 1962; 92: 545-552
69. MIDDLETON PG, CULLUP H, DICKINSON AM, et al. Vitamin D receptor gene polymorphism associates with graft-versus- host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation. Bone Marrow Transplant 2002; 30: 223-228.
70. PAKKALA I, TASKINEN E, PAKKALA S, et al. MC1288, a vitamin D analog, prevents acute graft-versus-host disease in rat bone marrow transplantation. Bone Marrow Transplant 2001; 27: 863-867. (Pubitemid 32496421)
71. ADORINI L, PENNA G, CASORATI M, et al. Induction of transplantation tolerance by 1,25-dihydroxyvitamin D(3). Transplant Proc 2001; 33: 58-59
72. MARCELLUS DC, ALTOMONTE VL, FARMER ER, et al. Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease. Blood 1999; 93: 66-70
73. STOSIC-GRUJICIC S, EJDUS L, MIJATOVIC S, et al. Etretinate prevents autoimmune syndrome associated with chronic graft-versus-host disease in rats. Transplant Proc 1996; 28: 3258
74. SAURAT JH. Retinoids for cutaneous graft-versus-host disease, topical or systemic? Bone Marrow Transplant. 1991; 7: 249
75. GRYN J, CRILLEY P. Tretinoin for the treatment of cutaneous graft-versus-host disease. Bone Marrow Transplant 1990; 5: 279-280 (Pubitemid 20204447)
76. ROSS AC. Retinoid production and catabolism: role of diet in regulating retinol esterification and retinoic acid oxidation. J Nutr 2003; 133: 291S-296S
77. ROSS AC. Cellular metabolism and activation of retinoids: roles of cellular retinoid-binding proteins.FASEB J 1993; 7: 317-327
78. ROSS AC. Mutations in the gene encoding retinol binding protein and retinol deficiency: is there compensation by retinyl esters and retinoic acid? Am J Clin Nutr 1999; 69: 829-830
79. ZILE MH. Function of vitamin A in vertebrate embryonic development. J Nutr 2001; 131: 705-708
80. MOULAS AN, GEROGIANNI IC, PAPADOPOULOS D, et al. Serum retinoic acid, retinol and retinyl palmitate levels in patients with lung cancer. Respirology 2006 11: 169-174
81. SEDJO RL, RANGER-MOORE J, FOOTE J, et al. Circulating endogenous retinoic acid concentrations among participants enrolled in a randomized placebo-controlled clinical trial of retinyl palmitate. Cancer Epidemiol Biomarkers Prev 2004; 13: 1687-1692.
82. HARTMANN S, BRORS O, BOCK J, et al. Wiegand UW, et al.Exposure to retinoic acids in nonpregnant women following high vitamin A intake with a liver meal. Int J Vitam Nutr Res 2005; 75: 187-194
83. ROSALES FJ, RITTER SJ, ZOLFAGHARI R, et al. Effects of acute inflammation on plasma retinol, retinol-binding protein, and its mRNA in the liver and kidneys of vitamin A-sufficient rats. J Lipid Res 1996; 37: 962-971
84. ROSALES FJ, ROSS AC. Acute inflammation induces hyporetinemia and modifies the plasma and tissue response to Vitamin A supplementation in marginally vitamin A-deficient rats. J Nutr 1998; 128: 960-966
85. CLEMENS MR, LADNER C, EHNINGER G, et al. Plasma vitamin E and beta-carotene concentrations during radiochemotherapy preceding bone marrow transplantation. Am J Clin Nutr 1990; 51: 216-219 (Pubitemid 20068400)
86. CLEMENS MR, LADNER C, SCHMIDT H, et al. Decreased essential antioxidants and increased lipid hydroperoxides following high-dose radiochemotherapy. Free Radic Res Commun 1989; 7: 227-232
87. HUNNISETT A, DAVIES S, McLAREN-HOWARD J, et al. Lipoperoxides as an index of free radical activity in bone marrow transplant recipients. Preliminary observations. Biol Trace Elem Res 1995; 47: 125-132
88. JONAS CR, PUCKETT AB, JONES DP, et al. Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr 2000; 72:181-189.
89. AZAIS V, RACHMAN F, GROS S, et al. Cyclosporine administration decreases liver vitamin A stores in normal and vitamin A-deficient rats. Drug Nutr Interact 1987; 5: 81-88
90. WALD N, IDLE M, BOREHAM J, et al. Low serum-vitamin- A and subsequent risk of cancer. Preliminary results of a prospective study. Lancet 1980; 2: 813-815
91. BICHLER E. Plasma levels of retinol and retinol-binding protein in patients with squamous cell carcinomas of the head and neck region. Arch Otorhinolaryngol 1982; 236: 115-121
92. MUGLISTON T, COE A. Serum vitamin A levels in patients with untreated T1 or T2 squamous carcinoma of the larynx: a pilot study. ORL J Otorhinolaryngol Relat Spec 1986; 48: 261-264
93. de VRIES N, SNOW GB. Relationships of vitamins A and E and beta-carotene serum levels to head and neck cancer patients with and without second primary tumors. Eur Arch Otorhinolaryngol 1990; 247: 368-370
94. SIU TO, BASU T, JERRY LM. Zinc, carotene, and retinol in melanoma and non-melanoma skin cancer. In Vivo 1991; 5: 65-68
95. FELIX EL, LOYD B, COHEN MH. Inhibition of the growth and development of a transplantable murine melanoma by vitamin A. Science 1975; 189: 886-1868
96. EGAN KM, SOSMAN JA, BLOT WJ. Sunlight and reduced risk of cancer: Is the real story vitamin D? J Natl Cancer Inst 2005; 97: 161-163
97. CHIDA K, HASHIBA H, FUKUSHIMA M, et al. Inhibition of tumor promotion in mouse skin by 1 alpha, 25-dihydroxyvitamin D3. Cancer Res 1985; 45: 5426-5430 (Pubitemid 16200798)
98. SATAKE K, TAKAGI E, ISHII A, et al. Anti-tumor effect of vitamin A and D on head and neck squamous cell carcinoma. Auris Nasus Larynx 2003; 30: 403-412 (Pubitemid 37491325)
99. ABE M, AKENO N, OHIDA S, et al. Inhibitory effects of 1,25-dihydroxyvitamin D3 and 9-cisretinoic acid on parathyroid hormone-related protein expression by oral cancer cells (HSC-3). J Endocrinol 1998; 156: 349-357
100. PETKOVICH PM, HEERSCHE JN, TINKER DO, et al. Retinoic acid stimulates 1,25-dihydroxyvitamin D3 binding in rat osteosarcoma cells. J Biol Chem 1984; 259: 8274-8280 (Pubitemid 14090575)
101. SCHRADER M, BENDIK I, BECKER-ANDRE M, et al. Interaction between retinoic acid and vitamin D signalling pathways. J Biol Chem 1993; 268: 17830-17836 (Pubitemid 23260293)
102. TAVERA-MENDOZA L, WANG TT, LALLEMANT B, et al. Convergence of vitamin D and retinoic acid signalling at a common hormone response element. EMBO Rep 2006; 7: 180-185
103. HONG WK, LIPPMAN SM, ITRI LM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of head and neck. N Engl J Med 1990; 323: 795-801
104. BOREK C. Cellular transformation by radiation: induction, promotion, and inhibition. J Supramol Struct Cell Biochem 1981; 16: 311-336
105. MILLER RC, GEARD CR, OSMAK RS, et al. Modification of sister chromatid exchanges and radiation-induced transformation in rodent cells by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate and two retinoids. Cancer Res 1981; 41: 655-659
106. SMINIA P, van der KRACHT AH, FREDERIKS WM, et al. Hyperthermia, radiation carcinogenesis and the protective potential of vitamin A and N-acetylcysteine. J Cancer Res Clin Oncol 1996; 22: 343-350
107. CALAF GM, EMENAKER NJ, HEI TK. Effect of retinol on radiation- and estrogen-induced neoplastic transformation of human breast epithelial cells. Oncol Rep 2005; 13: 1017-1027
108. DEFACQUE H, SEVILLA C, PIQUEMAL D, et al. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signalling pathways. Leukemia 1997; 11: 221-227
109. BAEK JH, SOHN SK, KIM DH, et al. Wernicke's encephalopathy after allogeneic stem cell transplantation.Bone Marrow Transplant 2005; 35: 829-830[